ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Fight Back! Win the War Being Waged Against Your Immune System

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Vitamin D supplementation extends life in mouse model of Huntington's disease

Omega-3 fatty acid stops known trigger of lupus

Conquer Your Email Inbox, Increase Productivity and Reduce Stress

Print Page
Email Article

Infections Linked to Mental Decline in Elderly

  [ 105 votes ]   [ Discuss This Article ] • August 15, 2003

DALLAS, Aug. 15 – Infection by several common viruses can significantly increase the risk of dementia in the elderly with cardiovascular disease, according to a report in today's rapid access issue of Stroke: Journal of the American Heart Association.

Finnish researchers tested 383 cardiovascular disease patients for antibodies to the viruses herpes simplex type 1 (HSV1), herpes simplex type 2 (HSV2), and cytomegalovirus (CMV). Antibodies in the blood indicate a current or previous infection by the viruses.

People with antibodies to two of the viruses had a 1.8 times greater risk of dementia than those infected by none or one of the viruses. Those infected by all three viruses had a 2.3 times higher risk. The researchers selected the three viruses because several studies have suggested a link between each of them and dementia.

"Inflammation has been implicated in dementia, and viral infections could be a triggering factor," says lead author Timo E. Strandberg, M.D., Ph.D. "Our findings should be tested in other studies, but if these viruses are involved, there are existing therapies such as vaccination and antiviral drugs that could be used to prevent or treat dementia."

HSV1 causes cold sores and HSV2 is a sexually transmitted disease. CMV infects between 50 percent and 85 percent of U.S. adults by age 40, but it causes few symptoms and no long term health consequences in most healthy persons if they acquire it after birth.

The study involved participants in Finland's Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study, an effort to seek out prevention strategies for several diseases.

All participants had atherosclerosis and lived at home when they began the study. Their average age was 80; 65 percent were female; 82 percent had coronary artery disease, and 37 percent had suffered at least one stroke.

As part of the DEBATE study, researchers assessed patients' cognitive abilities each year using two well established tests, the Mini-Mental State Examination (MMSE) and the Clinical Dementia Rating (CDR). Cognitive impairment is associated with dementia in old age.

Scientists compared the MMSE and CDR scores of patients when they entered the DEBATE study with the scores of 348 patients who were alive and retested one year later.

The maximum score on the MMSE is 30, and a score below 24 points usually indicates clinically significant cognitive impairment, says Strandberg, a senior lecturer at the University of Helsinki and a senior researcher at the Academy of Finland.

"We found a significant association between cognitive status and the viral burden at baseline," Strandberg says. At baseline, participants with exposure to all three viruses were 2.5 times more likely to have cognitive impairment than those with antibodies to fewer than three.

MMSE scores declined as viral burden increased: average MMSE was 26.9 for those showing infection by zero or one virus; 26.5 for those with antibodies to two viruses, and 25.8 for participants with antibodies to all three of the viruses. The median MMSE score for those entering the DEBATE study was 27 with 58 participants scoring below 24. Forty-eight individuals had antibodies to none or one of the viruses; 229 showed previous infection by two viruses; and 106 had antibodies to all three.

In addition, abnormal clinical dementia rating scores were found in 4.9 percent of participants with exposure to zero or one virus, in 16.2 percent of those exposed to two viruses, and in 26.9 percent of participants exposed to all three.

At one year, the risk for cognitive impairment was 2.3 times higher for people with antibodies to all three viruses and 1.8 times higher for those with antibodies to two compared to those with one or no antibodies.

Researchers also tested patients for infection by the two bacteria: Chlamydia pneumoniae, which causes respiratory diseases, and Mycoplasma pneumoniae, which causes "walking pneumonia." The microorganisms have been associated with atherosclerosis and late onset dementia, including Alzheimer's, which is increasingly considered a vascular disease, Strandberg says.

They found that 79 patients (20.6 percent) had no antibodies to either; 182 (47.5 percent) had antibodies to one of the bacterium; and 122 (31.9 percent) had been infected by both. However, the researchers found no association between bacterial infection and a patient's decline in cognitive powers.

"Either bacteria are not involved, or we could not discern their effects," he says. Because all of the participants suffered from cardiovascular disease, the researchers could not determine whether the ailment played a role independent of the viruses in lowering the cognitive scores of participants.

Co-authors are Kaisu H. Pitkala, M.D., Ph.D.; Kimmo H. Linnavuori, M.D., Ph.D.; and Reijo S. Tilvis, M.D., Ph.D.

Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor®

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Coconut Oil - Healthy Gifts from the 'Tree of Life' Coconut Oil - Healthy Gifts from the 'Tree of Life'
Fatigue & Fibro Fog: Could You Have a B-12 Deficiency? Fatigue & Fibro Fog: Could You Have a B-12 Deficiency?
The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS
Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery Energy Breakthrough - One Fibromyalgia Patient’s Fortuitous Discovery
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map